Study ID | Study follow‐up (months) | ChAdOx1 (n) | SII‐ChAdOx (n) | Critical outcomes | ||||||
Confirmed SARS‐CoV‐2 infection after complete vaccination | Confirmed symptomatic COVID‐19 after complete vaccination | Severe or critical COVID‐19 | All‐cause mortality | Systemic reactogenicity events | Any AE | AE | ||||
Kulkarni 2021 (CTRI/2020/08/027170) | 6 | 300 | 100 | * | * | * | ✓ | ✓ | ✓ | ✓ |